Colorectal cancer trials in China

In China 616 Also abroad 1941

616 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 3Not yet taking people in China
FOLFIRI Plus Bevacizuamb and QL1706 in Second-Line Treatment for mCRC
Where
Guangzhou
Age
18 years and over
People
270
Run by
Sun Yat-sen University
See details and how to joinNCT07729605
Phase 2Taking people
Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Tislelizumab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement
Where
Shantou
Age
18 years to 75 years
People
51
Run by
Affiliated Cancer Hospital of Shantou University Medical College
See details and how to joinNCT07104604
Phase 2Taking people
Fruquintinib Plus Anti-EGFR Antibody for Third-Line Treatment of RAS Wild-Type mCRC
Where
Beijing
Age
18 years to 75 years
People
46
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07724223
Phase 2Taking people
PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
Where
Beijing, Changchun, Chengdu, Guangzhou, Hangzhou, Harbin, Jinan, Shanghai, Wuhan
Age
18 years and over
People
100
Run by
Biotheus Inc.
See details and how to joinNCT07133750
Phase 1Taking people
Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors
Where
Tianjin
Age
18 years and over
People
493
Run by
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
See details and how to joinNCT07589205
No phaseNot yet taking people in China
Development and Validation of a Colorectal Cancer Diagnostic Model
Where
Beijing, Fuzhou, Xiamen, Yinchuan
Age
18 years to 80 years
People
20,000
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT07692555
Phase 3Taking people
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Where
Beijing, Changsha, Changzhou, Chengde, Chongqing, Fuzhou, Guangzhou, Haikou, Hangzhou, Harbin, Jinan, Jinzhou, Lanzhou, Linyi, Meizhou, Nanchang, Nanyang, Shanghai, Shenyang, Suzhou, Taiyuan, Tangshan, Wuhan, Xuzhou, Zhengzhou
Age
18 years and over
People
400 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05253651 · EU 2024-514180-25-00
Phase 1Taking people
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Where
Guangzhou, Jinan, Shanghai
Age
18 years and over
People
914 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00
Phase 2Enrolling by invitation
Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer
Where
Shanghai
Age
18 years to 75 years
People
16
Run by
Fudan University
See details and how to joinNCT07441369
Phase 2Taking people
Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer
Where
Nanjing
Age
18 years to 75 years
People
43
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07718490
Phase 2Not yet taking people in China
Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer
Where
Guangzhou
Age
18 years and over
People
91
Run by
Sun Yat-sen University
See details and how to joinNCT07714447
No phaseTaking people
The Impact of Immune Cell Changes During the Perioperative Period on the Prognosis of Patients With Colorectal Cancer
Where
Beijing
Age
18 years to 85 years
People
7,000
Run by
Beijing Friendship Hospital
See details and how to joinNCT05015296
No phaseNot yet taking people in China
The Correlation of Postoperative Polyp Recurrence and Colorectal Cancer
Where
Lanzhou
Age
18 years to 80 years
People
3,000
Run by
Gansu Provincial Hospital
See details and how to joinNCT07708415
No phaseTaking people
The Value of Bowel Sounds in Evaluating Postoperative Intestinal Function Recovery in Colorectal Cancer Patients
Where
Wuhan
Age
18 years to 90 years
People
172
Run by
Zhongnan Hospital
See details and how to joinNCT07705139
Phase 2Not yet taking people in China
SHR-A1904 in Advanced Colorectal Cancer: an Exploratory Study
Where
Beijing
Age
18 years to 75 years
People
17
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT07700719
Phase 2Taking people
A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.
Where
Shanghai
Age
18 years to 80 years
People
95
Run by
Fudan University
See details and how to joinNCT06889610
Phase 2Not yet taking people in China
Serplulimab Plus Decitabine and CAPOX Before Surgery for Locally Advanced Colorectal Cancer
Where
Tianjin
Age
18 years and over
People
35
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07691632
No phaseTaking people
Stage II/III Colorectal Cancer Recurrence
Where
Dalian
Age
18 years and over
People
400 worldwide
Run by
City of Hope Medical Center
See details and how to joinNCT06314958
No phaseTaking people
Early Detection of Advanced Adenomas and Colorectal Cancer
Where
Dalian
Age
18 years and over
People
2,000 worldwide
Run by
City of Hope Medical Center
See details and how to joinNCT06342440
Phase 2Taking people
Standard Second-line Therapy With ONgericimab and TOripalimab in pMMR/MSS Colorectal Cancer: a Single-arm Phase II Trial
Where
Shanghai
Age
18 years to 75 years
People
32
Run by
Shanghai Pudong Hospital
See details and how to joinNCT07106034
Phase 1/2Not yet taking people in China
Savolitinib Plus Cetuximab and FOLFOX Chemotherapy for RAS/BRAF Wild-type Metastatic Colorectal Cancer
Where
Shanghai
Age
18 years to 75 years
People
138
Run by
Fudan University
See details and how to joinNCT07683403
Phase 1Taking people
A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies
Where
Changchun, Changsha, Fuzhou, Guangzhou, Hangzhou, Harbin, Kunming, Luoyang, Nanchang, Shanghai, Shenyang, Wuhan
Age
18 years and over
People
214
Run by
Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT06839105
Phase 3Taking people
SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC
Where
Guangzhou
Age
18 years to 75 years
People
204
Run by
Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07549399
No phaseTaking people
Circulating Tumor DNA (ctDNA) as a Predictive Biomarker for Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H Colorectal Patients
Where
Beijing, Shanghai
Age
18 years to 80 years
People
60
Run by
Geneplus-Beijing Co. Ltd.
See details and how to joinNCT06098560
Phase 3Taking people
SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases
Where
Guangzhou
Age
18 years to 75 years
People
24
Run by
Jun Huang
See details and how to joinNCT06794086